Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00186147 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bone Marrow Grafting for Leukemia and Lymphoma

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Amendment history

  1. Minor

    6 amendments

    6 re-verifications since 2020-08-26, no change to tracked fields

    v23-v28

  2. Notable

    Primary completion date: Dec 2018 to Dec 2069

    Trial status: Recruiting to Enrolling by Invitation; Completion date: Dec 2019 to Dec 2069; Site details revised

    Study Identification, Study Status, Oversight, Contacts/Locationsv22

  3. Minor

    Study description expanded, about 12 words

    Show what changed: Study description
    The purpose of this study is to obtainacquire critical tissue and biological samples forthat ongoingcan studiesbe regardingevaluated to elucidate underlying mechanisms of disease control, transplant outcomesrelated complications and complications.overall outcomes

    Study Identification, Study Status, Oversight, Study Description, Eligibility, IPDSharingv21

  4. Minor

    2 amendments

    2 re-verifications since 2016-04-21, no change to tracked fields

    v19-v20

  5. Minor

    Site contact updated

    Study Status, Contacts/Locationsv18

Show 16 earlier versions

  1. Minor

    Study Status, Study Description, Outcome Measures

    v17

  2. Minor

    Study Status

    Re-verified, no change to tracked fields

    v16

  3. Minor

    Site contact updated

    Study Status, Contacts/Locationsv15

  4. Minor

    Site contact updated

    Study Status, Contacts/Locationsv14

  5. Minor

    2 amendments

    2 re-verifications since 2012-10-31, no change to tracked fields

    v12-v13

  6. Minor

    Primary completion date: Dec 2018

    Completion date: Dec 2019; Eligibility criteria revised; Site contact updated; and 1 more

    Show all 5 changes in this update
    • Minor Primary completion date: Dec 2018
    • Minor Completion date: Dec 2019
    • Minor Eligibility criteria revised
      Show what changed
      Inclusion Criteria:- All hematopoietic cell transplant recipients and donors who agree to participate
 Exclusion Criteria:- Subject does not agree to participate
    • Minor Site contact updated
    • Minor Study arms: 0 to 1

    Study Status, Sponsor/Collaborators, Study Design, Arms and Interventions, Eligibility, Contacts/Locationsv11

  7. Minor

    Eligibility criteria revised

    Site contact updated

    Show what changed: Eligibility criteria
    Inclusion Criteria:- All hematopoietic cell transplant recipients and donors who agree to participate
 Exclusion Criteria:- Subject does not agree to participate

    Study Identification, Study Status, Eligibility, Contacts/Locationsv10

  8. Minor

    Study Status

    Re-verified, no change to tracked fields

    v9

  9. Minor

    Enrollment target: 9999

    Eligibility criteria revised; Study description expanded, about 18 words; Study site revised; and 1 more

    Show all 5 changes in this update
    • Minor Enrollment target: 9999
    • Minor Eligibility criteria revised
      Show what changed
      Inclusion Criteria:- All hematopoietic cell transplant recipients and donors who agree to participate Exclusion Criteria:- Subject does not agree to participate
    • Minor Study description expanded, about 18 words
      Show what changed
      The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.
    • Minor Study site revised
      Show what changed
      Stanford University CancerSchool Centerof Medicine
    • Minor Collaborators: 1 to 2
      Show what changed
      National Cancer Institute (NCI)

    Study Identification, Study Status, Sponsor/Collaborators, Oversight, Study Description, Conditions, Study Design, Eligibility, Contacts/Locationsv8

  10. Minor

    Collaborator revised

    Show what changed: Collaborators
    National CancerInstitutes Instituteof Health (NCINIH)

    Study Status, Sponsor/Collaboratorsv7

  11. Minor

    3 amendments

    3 re-verifications since 2006-07-05, no change to tracked fields

    v4-v6

  12. Minor

    Study Status, Study Description, Conditions, Eligibility, Contacts/Locations

    v3

  13. Minor

    Study Status

    Re-verified, no change to tracked fields

    v2

  1. Minor

    Study First Submitted

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stanford University
633 trials monitored
See 46 trials at risk
Leukemia
2,566 trials monitored
See 143 trials at risk
The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.
Trial Details
NCT Number NCT00186147
Lead Sponsor Stanford University
Collaborators: National Cancer Institute (NCI), National Institutes of Health (NIH)
Conditions Leukemia, Lymphoma, Hematologic Diseases
Enrollment 9,999 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov